Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. (Q54581100)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. |
scientific article |
Statements
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. (English)
Eliane Gluckman
Philippe Rousselot
Francoise Huguet
Laurence Legros
Jean Michel Cayuela
Odile Maarek
Odile Blanchet
Gerald Marit
Josy Reiffers
Martine Gardembas
François-Xavier Mahon
14 September 2006
109
1
58-60